The Calibr-Skaggs Institute for Innovative Medicines is a pioneering translational research institute dedicated to accelerating the next generation of medicines for critical unmet needs. We are a leading nonprofit drug discovery engine bringing treatments from discovery into the clinic across multiple disease areas. As a division of Scripps Research—the largest private, nonprofit biomedical research organization in the United States ranked for its impact on innovation—we leverage a wide range of world-renowned, pioneering scientific approaches and technologies. Our self-sustaining model encourages bold exploration of ideas with far-reaching impact, while facilitating the transition of these ideas into clinical development.